All drugs decrease the moality in hea failure except:
High-Yield Explanation
Digoxin is used in acute CHF as well as maintenance therapy but do not retard cardiac remodelling or prolong survival in CHF patients Drugs that decrease the cardiac remodeling in a patient with CHF decrease the moality. They are: Beta blockers (metoprolol, bisoprolol) ACE inhibitors (enalapril) ARB (telmisaan) Aldosterone antagonist (spironolactone) Note Telmisaan is an ARB which has PPAR gamma agonist activity